PLATELET-ADHESION TO FIBRONECTIN IN FLOW - DEPENDENCE ON SURFACE CONCENTRATION AND SHEAR RATE, ROLE OF PLATELET MEMBRANE-GLYCOPROTEINS GP IIB/IIIA AND VLA-5, AND INHIBITION BY HEPARIN

被引:73
作者
BEUMER, S
IJSSELDIJK, MJW
DEGROOT, PG
SIXMA, JJ
机构
关键词
D O I
10.1182/blood.V84.11.3724.bloodjournal84113724
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Platelet adhesion to purified surface-immobilized fibronectin under flow conditions was investigated. Fibronectin was found to support attachment and spreading of platelets. The extent of platelet spreading depended on the amount of immobilized fibronectin. An antiglycoprotein (anti-GP) IIIb/IIIa antibody and an Arg-Gly-Asp (RGD)-containing peptide inhibited adhesion almost completely, whereas antibodies directed against platelet GP Ic/IIa (very late antigen 5) inhibited by 50%. Similar results with the antibodies and the peptide were found in a static system. A comparison of different anticoagulants showed no difference in adhesion using citrate or hirudin. However, unfractionated heparin (UFH) or low-molecular-weight heparin (LMWH) as the only anticoagulant or in combination with citrate maximally inhibited adhesion by 80% and 60%, respectively. Preincubation of the immobilized fibronectin with UFH resulted in a maximal inhibition of 90%, whereas preincubation with LMWH had no effect. When we preincubated the surface with heparins of different size, we observed 40% inhibition of adhesion with heparins with an average MW of up to 18 kD, whereas a heparin with an average MW of 21 kD almost completely blocked adhesion. These results indicate that platelet adhesion to fibronectin in flow involves several receptors, is highly RGD-mediated, does not require physiologic levels of divalent cations, and can be inhibited by direct binding of heparin to the fibronectin surface. (C) 1994 by The American Society of Hematology.
引用
收藏
页码:3724 / 3733
页数:10
相关论文
共 51 条
[1]   THROMBOSPONDIN PLATELET INTERACTIONS - ROLE OF DIVALENT-CATIONS, WALL SHEAR RATE, AND PLATELET MEMBRANE-GLYCOPROTEINS [J].
AGBANYO, FR ;
SIXMA, JJ ;
DEGROOT, PG ;
LANGUINO, LR ;
PLOW, EF .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (01) :288-296
[2]  
AOTA S, 1991, J BIOL CHEM, V266, P15938
[3]  
BASTIDA E, 1987, BLOOD, V70, P1437
[4]  
BOWDITCH RD, 1991, J BIOL CHEM, V266, P23323
[5]   RECYCLING OF PLATELET PHOSPHORYLATION AND CYTOSKELETAL ASSEMBLY [J].
COX, AC ;
CARROLL, RC ;
WHITE, JG ;
RAO, GHR .
JOURNAL OF CELL BIOLOGY, 1984, 98 (01) :8-15
[6]  
DEGROOT PG, 1990, BRIT J HAEMATOL, V75, P308
[7]   INHIBITION OF PLATELET-AGGREGATION BY A MONOCLONAL-ANTIBODY AGAINST HUMAN FIBRONECTIN [J].
DIXIT, VM ;
HAVERSTICK, DM ;
OROURKE, K ;
HENNESSY, SW ;
BROEKELMANN, TJ ;
MCDONALD, JA ;
GRANT, GA ;
SANTORO, SA ;
FRAZIER, WA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (11) :3844-3848
[8]   HEPARIN NEUTRALIZATION BY PLATELET-RICH THROMBI - ROLE OF PLATELET FACTOR-4 [J].
EITZMAN, DT ;
CHI, L ;
SAGGIN, L ;
SCHWARTZ, RS ;
LUCCHESI, BR ;
FAY, WP .
CIRCULATION, 1994, 89 (04) :1523-1529
[9]  
FOX JEB, 1993, J BIOL CHEM, V268, P25973
[10]  
FOX JEB, 1987, J BIOL CHEM, V262, P12627